Turing Hires Lobbyists in Response to Controversy Surrounding Drug Pricing

October 2, 2015

The Hill (Wilson, 10/2) reported that, according to disclosure forms, “Turing Pharmaceuticals hired lobbyists at Buchanan Ingersoll & Rooney to work on ‘strategy development and implementation of the company’s federal government relations initiatives’.” The forms were dated about a week after Turing’s CEO raised the cost of a drug “from $13.50 per pill to $750 per pill.”